High expression of myeloid-related proteins 8 and 14 characterizes an inflammatorily active but ineffective response of macrophages during leprosy

Immunology

Volumn 111, Issue 4, 2004, Pages 472-480

  Sunderkötter, Cord H ^a,c   Tomimori Yamashita, Jane ^b   Nix, Verena ^a   Maeda, Solange M ^b   Sindrilaru, Anca ^a,c   Mariano, Mario ^b   Sorg, Clemens ^a   Roth, Johannes ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORDANE; MYELOID RELATED PROTEIN 14; MYELOID RELATED PROTEIN 8; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BORDERLINE LEPROSY; CELL SECRETION; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIOID CELL; ERYTHEMA NODOSUM LEPROSUM; GIANT CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LEPROSY; MACROPHAGE ACTIVATION; MULTIBACILLARY LEPROSY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVERSAL REACTION; TUBERCULOID LEPROSY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CALGRANULIN A; CALGRANULIN B; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; ERYTHEMA NODOSUM; HUMANS; IMMUNOENZYME TECHNIQUES; LEPROSY; LEPROSY, LEPROMATOUS; LEPROSY, TUBERCULOID; MACROPHAGES; MIDDLE AGED; SKIN; UP-REGULATION;

EID: 18544401856     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0019-2805.2004.01836.x     Document Type: Article

References (47)

1. Rutherford MS, Witsell A, Schook LB. Mechanisms generating functionally heterogeneous macrophages: chaos revisited. J Leukoc Biol 1993; 53:602-18.
2. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leukoc Biol 1994; 55:410-22.
3. Bresnihan B, Alvaro-Gracia JM, Cobby M et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 1998; 41:2196-204.
4. Frosch M, Strey A, Vogl T et al. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2000; 43:628-37.
5. Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 1994; 35: 669-74.
6. Sunderkotter C, Kunz M, Steinbrink K, Meinardus-Hager G, Goebeler M, Bildau H, Sorg C. Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo. J Immunol 1993; 151:4891-901.
7. Steinbrink K, Schonlau F, Rescher U, Henseleit U, Vogel T, Sorg C, Sunderkotter C. Ineffective elimination of Leishmania major by inflammatory (MRP14-positive) subtype of monocytic cells. Immunobiology 2000; 202:442-59.
8. Odink K, Cerletti N, Bruggen J et al. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987; 330:80-2.
9. Roth J, Vogl T, Sorg C, Sunderkotter C. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 2003; 24:155-8.
10. Roth J, Goebeler M, van den Bos C, Sorg C. Expression of calcium-binding proteins MRP8 and MRP14 is associated with distinct monocytic differentiation pathways in HL-60 cells. Biochem Biophys Res Commun 1993; 191:565-70.
11. Hessian PA, Edgeworth J, Hogg N. MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J Leukoc Biol 1993; 53:197-204.
12. Roth J, Sunderkotter C, Goebeler M, Gutwald J, Sorg C. Expression of the calcium-binding proteins MRP8 and MRP14 by early infiltrating cells in experimental contact dermatitis. Int Arch Allergy Immunol 1992; 98:140-5.
13. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997; 272:9496-502.
14. Barthe C, Figarella C, Carrere J, Guy-Crotte O. Identification of 'cystic fibrosis protein' as a complex of two calcium-binding proteins present in human cells of myeloid origin. Biochim Biophys Acta 1991; 1096:175-7.
15. Hammer HB, Kvien TK, Glennas A, Melby K. A longitudinal study of calprotectin as an inflammatory marker in patients with reactive arthritis. Clin Exp Rheumatol 1995; 13:59-64.
16. Veale DJ, Barnes L, Rogers S, FitzGerald O. Immunohistochemical markers for arthritis in psoriasis. Ann Rheum Dis 1994; 53:450-4.
17. Tibble J, Teahon K, Thjodleifsson B et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000; 47:506-13.
18. Abulafia J, Vignale RA. Leprosy: accessory immune system as effector of infectious, metabolic, and immunologic reactions. Int J Dermatol 2001; 40:673-87.
19. Haimanot RT, Melaku Z. Leprosy. Curr Opin Neurol 2000; 13: 317-22.
20. Jacobson RR, Krahenbuhl JL. Leprosy. Lancet 1999; 353: 655-60.
21. Abulafia J, Vignale RA. Leprosy: pathogenesis updated. Int J Dermatol 1999; 38:321-34.
22. Verhagen CE, Wierenga EA, Buffing AA, Chand MA, Faber WR, Das PK. Reversal reaction in borderline leprosy is associated with a polarized shift to type 1-like Mycobacterium leprae T cell reactivity in lesional skin: a follow-up study. J Immunol 1997; 159:4474-83.
23. Murphy GF, Sanchez NP, Flynn TC, Sanchez JL, Mihm MC Jr, Soter NA. Erythema nodosum leprosum: nature and extent of the cutaneous microvascular alterations. J Am Acad Dermatol 1986; 14:59-69.
24. Meyerson MS. Erythema nodosum leprosum. Int J Dermatol 1996; 35:389-92.
25. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 1966; 34:255-73.
26. Pulford KA, Rigney EM, Micklem KJ, Jones M, Stross WP, Gatter KC, Mason DY. KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 1989; 42:414-21.
27. Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993; 81:1607-13.
28. Roth J, Burwinkel F, van den Bos C, Goebeler M, Vollmer E, Sorg C. MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood 1993; 82, 1875-83.
29. van den Bos C, Rammes A, Vogl T, Boynton R, Zaia J, Sorg C, Roth J. Copurification of P6, MRP8, and MRP14 from human granulocytes and separation of individual proteins. Protein Expr Purif 1998; 13:313-8.
30. Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003; 73:209-12.
31. Goebeler M, Roth J, Burwinkel F, Vollmer E, Bocker W, Sorg C. Expression and complex formation of S 100-like proteins MRP8 and MRP14 by macrophages during renal allograft rejection. Transplantation 1994; 58:355-61.
32. Berntzen HB, Olmez U, Fagerhol MK, Munthe E. The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 1991; 20: 74-82.
33. Goebeler M, Roth J, Henseleit U, Sunderkotter C, Sorg C. Expression and complex assembly of calcium-binding proteins MRP8 and MRP14 during differentiation of murine myelomonocytic cells. J Leukoc Biol 1993; 53:11-8.
34. 2 vitamin D3 enhances expression of the genes encoding Ca(2+)-binding proteins MRP-8 and MRP-14. Am J Physiol 1992; 262:C235-42.
35. Kuruto R, Nozawa R, Takeishi K, Arai K, Yokota T, Takasaki Y. Myeloid calcium binding proteins: expression in the differentiated HL-60 cells and detection in sera of patients with connective tissue diseases. J Biochem Tokyo 1990; 108:650-3.
36. Hu SP, Harrison C, Xu K, Cornish CJ, Geczy CL. Induction of the chemotactic S100 protein, CP-10, in monocyte/macrophages by lipopolysaccharide. Blood 1996; 87:3919-28.
37. Seeliger S, Vogl T, Engels IH, Schröder M, Sorg C, Sunderkötter C, Roth J. Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases. Am J Pathol 2003; 163:947-56.
38. Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990; 336:763-5.
39. Sohnle PG, Hunter MJ, Hahn B, Chazin WJ. Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14). J Infect Dis 2000; 182: 1272-5.
40. Rugtveit J, Haraldsen G, Hogasen AK, Bakka A, Brandtzaeg P, Scott H. Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+ L1+ monocyte derived cells. Gut 1995; 37:367-73.
41. Yui S, Nakatani Y, Mikami M. Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull 2003; 26:753-60.
42. Roth J, Teigelkamp S, Wilke M, Grun L, Tummler B, Sorg C. Complex pattern of the myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. Immunobiology 1992; 186:304-14.
43. Brun JG, Jonsson R, Haga HJ. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol 1994; 21:733-8.
44. Hamann W, Floter A, Schmutzler W, Zwadlo-Klarwasser G. Characterization of a novel anti-inflammatory factor produced by RM3/1 macrophages derived from glucocorticoid treated human monocytes. Inflamm Res 1995; 44:535-40.
45. Sarno EN, Grau GE, Vieira LM, Nery JA. Serum levels of tumour necrosis factor-α and interleukin-1β during leprosy reactional states. Clin Exp Immunol 1991; 84:103-8.
46. Sunderkotter C, Steinbrink K, Henseleit U, Bosse R, Schwarz A, Vestweber D, Sorg C. Activated T cells induce expression of E-selectin in vitro and in an antigen-dependent manner in vivo. Eur J Immunol 1996; 26:1571-9.
47. Moncada B, Torres-Alvarez MB, Gonzalez-Amaro R, Fuentes-Ahumada C, Baranda L, Delgado SP, Garcia R. Lack of expression of intercellular adhesion molecule ICAM-1 in lepromatous leprosy patients. Int J Lepr Other Mycobact Dis 1993; 61:581-5.